Messoud Ashina
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea (NCT04419259) | Messoud Ashina | 2020-06-09 |
Track Messoud Ashina automatically
Every clearance here is in the API, with alerts when new ones post.